Novamab Stock

Novamab focuses on the research and development of new nanobodies.

Sign up today and learn more about Novamab Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Novamab Stock

Novamab focuses on the research and development of new nanobodies. The core members of the team have 15 years of experience in nanobody research and development, and are domestic nanobody "pioneers". At present, they have established an inhaled macromolecular drug research and development platform, an albumin nanobody long-acting platform and a nanobody double-antibody platform, etc., to give full play to nanobody The advantages of antibodies, the development of innovative nanobody drugs such as sprays and eye drops, to solve the pain points of clinical major chronic diseases in terms of administration methods, administration cycles, etc.

Funding History

March 2021$100M
December 2023$100M

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo